Get access to our best features
Get access to our best features
Published 2 months ago

Prescription drug affordability boards don't help lower the cost of medication

Summary by Ground News
The vote by the Prescription Drug Affordability Board kicks off a six-month process to determine what price would be appropriate for Enbrel. Opponents argue patients could lose access to drugs under a price ceiling. Supporters say drugmakers can't easily cut states out of their distribution chains and still make money.

0 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources lean Right
50% Right

To view factuality data please Upgrade to Premium


To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)